Innovations in Chronic UTI Treatment: The Llucern Device and Expert Insights

Join us for an insightful and informative webinar featuring a leading expert in chronic urinary tract infection (UTI) treatment. This session will also explore ground-breaking advancements in UTI diagnostics and management, including the Lodestar a new rapid, molecular testing platform, capable of providing highly accurate results in 35 minutes.

Featuring:

• Peter Nest, Founder of Sussex Biologicals
• Mr. Sachin Malde, Consultant Urological Surgeon at Guy's and St Thomas' NHS Foundation Trust

Session Highlights:

• The Llucern Device: Learn about this cutting-edge molecular diagnostic tool that offers rapid and accurate identification of the most common uropathogens responsible for chronic UTIs. The device utilises loop-mediated isothermal amplification (LAMP) technology to provide results in just 35 minutes, improving diagnostic accuracy and enabling personalised treatments for better patient outcomes. As the runner-up for the Longitude Prize, this device is paving the way for more effective UTI management while combating antimicrobial resistance (AMR).
• Sachin Malde's Approach to Chronic UTI Treatment: Mr. Malde will share his expert insights on the clinical management of chronic UTIs, including treatment strategies, personalised care plans, and his holistic approach to addressing this challenging condition. With years of experience and a strong focus on research and innovation, Mr. Malde’s approach to patient care has earned him recognition as a leader in urological care.

Who Should Attend:

This webinar is ideal for patients as well as healthcare professionals involved in the diagnosis and treatment of chronic UTIs, including urologists, nurses, and researchers. Whether you are looking to stay up to date on the latest diagnostic tools or seeking expert guidance on treatment strategies, this session will provide invaluable insights.

Register now to secure your place and take part in this exciting opportunity to learn from experts shaping the future of chronic UTI care.